INTRODUCTION
Chronic obstructive pulmonary disease (COPD) is a respiratory disease that has had great socioeconomic impact due to its high prevalence worldwide. 1 The prevalence of COPD in a population aged 40 years and older in São Paulo was found to be 15.8%, through the PLATINO study. 2 Epidemiological studies in European, Asian and North American countries have estimated the prevalence of COPD in their populations to be 5-25%, 3 with incidence rates ranging from 1.5-11%. [4] [5] [6] [7] [8] [9] [10] [11] This variability can be attributed to the different spirometry criteria used to diagnose the disease. 3 Among the spirometry criteria used in diagnosing airflow obstruction, the ones most commonly used are a fixed ratio of less than 0.7 between forced expiratory volume in one second (FEV 1 ) and forced vital capacity (FVC) (FEV 1 /FVC < 0.7) 12 and a FEV 1 /FVC ratio below the lower limit of normality (LLN), 13 which varies according to the subjects' age, height, race and sex, as obtained using reference equations. However, it has been suggested that using forced expiratory volume in six seconds (FEV 6 ) would be an alternative to FVC, since this is approximately 25% less variable than FVC 14 and is a good substitute for detecting airflow obstruction.
Measuring and monitoring a public health problem is the first step in elaborating public health administrative strategies. 15 Spirometry is essential in diagnosing COPD, 16 regardless of the spirometric criteria used to identify airflow obstruction. Therefore, this follow-up study, which includes the subjects who took part in the initial phase of the PLATINO study, 2 in São Paulo, is quite important, given that new cases of COPD can be identified using the same diagnostic procedures and that differences in the estimated incidence can be found in terms of the different spirometric criteria.
OBJECTIVE
The aim of the present study was to evaluate new cases of COPD at the end of a nine-year follow-up period, analyzing the same subjects who took part in the initial phase of the population-based PLATINO study in the city of São Paulo and taking into consideration three different diagnostic criteria: FEV 1 / FVC < 0.70 post-bronchodilator; FEV 1 /FVC < LLN post-bronchodilator; and FEV 1 /FEV 6 < LLN post-bronchodilator; and to identify the concordance of these criteria in the new cases.
METHODS

Sample and study design
The present study population was composed of the same subjects who took part in the initial phase of the pop- 
Diagnosis
The diagnosis of COPD was confirmed by means of spirometry, using a portable battery-powered spirometer and an ultrasound system (Easy One spirometer; NDD Medical Technologies, Andover, MA, USA, and Zurich, Switzerland) that was identical to those used in the initial phase of the PLATINO study. The subjects performed up to 15 forced expiratory maneuvers (which was the maximum accepted by the team in one session), in order to obtain three acceptable maneuvers yielding the highest FEV 1 and FVC values without exceeding a difference of 150 ml. Subsequently, an inhaled bronchodilator (salbutamol, 200 µg) was administered using a 500-ml spacer. The test was then repeated 15 minutes later. All spirometric tests were performed with the subjects seated and using a nose clip and a disposable mouthpiece. Only the expiratory phase was recorded.
In both the initial and the follow-up (2012) phase, the subjects were diagnosed using three criteria: FEV 1 /FVC < 0.70 post-bronchodilator;
12 FEV 1 /FVC < LLN post-bronchodilator; 13 and FEV 1 /FEV 6 < LLN post-bronchodilator. 17 The reference equation derived from the PLATINO study was used to calculate the predicted values and the LLN for 
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The present study was approved by the university's Research Ethics Committee (no. 04234/10). After being informed about the study and its procedures, all the subjects who agreed to participate provided written informed consent.
Statistical analysis
The data gathered during the follow-up phase of the PLATINO study were added to the original database of the initial phase of the study, which had been conducted in the city of São Paulo, Brazil, in 2003. The data analysis was performed using the Statistical Package for the Social Sciences, version 17.0 (SPSS Inc., Chicago, IL, USA), and the statistical significance level was set at P < 0.05.
Cumulative incidence refers to the number of onsets in a population at risk during a certain period. In this study, the new cases of COPD were obtained from among the subjects who developed the disease, in accordance with each spirometric diagnostic criterion, over the nine-year follow-up period.
Preexisting cases, individuals who did not take part in the follow-up phase and individuals who did not undergo spirometry in either the initial or the follow-up phase of the PLATINO study were not included in the incidence calculation. Subjects who reported having a medical diagnosis of asthma and cases of FEV 1 reversibility, as seen in the post-bronchodilator spirometry were considered eligible for analysis.
RESULTS
Out of the 1,000 subjects who took part in the initial phase of the PLATINO study, 944 were found again or information on their whereabouts after nine years was obtained. The reasons for the loss of follow-up were as follows: subject not found (n = 56), death (n = 135), refusal to participate (n = 141) and subject moved to another state/city and considered to be a "loss" (n = 55). Out of these 944 subjects, 613 took part in the follow-up phase of the study and 594 provided consent and underwent pre-bronchodilator and post-bronchodilator spirometry. The participants and non-participants (i.e. refusals, subject not found and subject who had moved to another state/city) of the follow-up PLATINO study had the same characteristics as the participants who took part in the initial phase of the study, in terms of sex, age, education level and pulmonary function. The only significant difference was in the proportion of former smokers, which was higher in the group of subjects who took part in the follow-up phase of the study, in relation to non-participants (37.6% versus 23.8%; P < 0.001). The data regarding the subjects who took part in the follow-up PLATINO study in São Paulo are presented in Figure 1 .
The demographic and clinical data on the subjects who took part in the initial phase (n = 1,000) and follow-up phase (n = 613) of the PLATINO study are presented in Table 1 .
At the end of the nine-year follow-up period, the subjects showed deterioration in the physical domain of quality of life. The proportion of smokers was different, and thus, the proportion of former smokers was higher.
The new cases of COPD at the end of the nine-year followup period varied in terms of the spirometric criterion used to diagnose the disease: FEV 1 /FVC < 0.7 showed the highest proportion of onsets ( Table 2 ). The three diagnostic criteria were concordant with regard to classifying six subjects who had COPD (Figure 2) . The criterion FEV 1 /FEV 6 < LLN with 
DISCUSSION
The results from this study showed that, at the end of a nine-year follow-up period, the rate of diagnosing new cases of COPD in a population-based sample in the city of São Paulo ranged from 1.4% to 4.0%, depending on the spirometric diagnostic criterion used. The guidelines available regarding COPD diagnosis and treatment 12, [19] [20] [21] differ in relation to the spirometric criteria used for identifying airflow obstruction, and there is controversy regarding which criterion is the most appropriate for diagnosing the disease.
The spirometric diagnostic criterion that takes a fixed FEV 1 / FVC ratio or a FEV 1 /FVC of 0.7 is simple and practical. However, it can increase the rates of false-positive results among older subjects and might not detect the disease in younger subjects (false-negative results). 22, 23 The increase in the number of falsepositive results is minimized when this criterion is based on the fifth percentile or taken as below the LLN. On the other hand, it has already been demonstrated that false-negative results are more common when such a criterion is used. Because of the resulting misdiagnoses, COPD patients are undertreated or even not treated in the initial stages of the disease, when they could benefit from treatment. 24 The criterion FEV 1 /FEV 6 < 0.75 or FEV 1 /FEV 6 < LLN has the advantages of being easy to apply, both for the evaluator and for the patient. This criterion can eliminate the limitation on low-flow accuracy at the end of the FVC maneuver and can reduce the time needed to perform the spirometry, as well as the chances of possible complications during the examination, such as syncope. [25] [26] [27] These diagnostic criteria present different sensitivities, specificities and positive and negative predictive values. 23, 24, 28, 29 Although the positive and negative points of each COPD diagnostic criterion have been identified, the historical divergences regarding the use of fixed ratios, LLN, and other criteria still remain in the literature. 30, 31 Therefore, further studies that aim to identify the diagnostic and prognostic markers of this disease are needed.
Hence, the present study evaluated the findings from new COPD cases in the city of São Paulo based on three different spirometric criteria. The incidence rate of COPD was lower (n = 7)
when FEV 1 /FVC < LLN was used, followed by FEV 1 /FEV 6 < LLN (n = 10) and the fixed-ratio criterion FEV 1 /FVC < 0.7 (n = 20).
Thus, according to the diagnostic criterion used, the number of new COPD cases may triple. This difference in the results was also reported previously in an incidence study 11 in which the results indicated that the number of cases could double. This large disparity probably reflects differences in sensitivity and specificity. 32 In divergent cases of airflow obstruction (e.g. FEV 1 / FVC < 0.7 and FEV 1 /FVC ≥ LLN), the subjects would not have clinically significant obstruction but would have a clinical profile characterized by significant comorbidities, thereby indicating that they could be at risk of developing COPD and should be followed up carefully. 33 Despite the disparities among the criteria, six subjects showed concordance regarding the incidence of airflow obstruction. The concordance between the criteria FEV 1 /FVC < 0.7 and FEV 1 /FVC < LLN was 35.0%, while de Marco et al. 11 reported concordance of 48% for these same criteria. The most discordant cases were associated with the criterion FEV 1 /FVC < 0.7, which was the only one to classify 11 subjects as new cases.
From investigating the characteristics of these 11 subjects in relation to the COPD cases with concordance in three criteria (n = 6), we found that 64% were 68 years of age or older (P = 0.04). Considering that aging contributes to airflow limitation, mainly due to increased thoracic wall rigidity and decreased pulmonary elastic recoil, 34, 35 these findings corroborate the assumption that the criterion FEV 1 /FVC < 0.7 may lead to misdiagnosing of COPD among the elderly through precluding the clinical distinction between disease and airflow limitation that is caused by the aging process. 13 paring the rate found in the present study with the rates obtained in other studies. This is because, in addition to the criterion used for diagnosing the disease, 38 there were differences in incidence rate, [9] [10] [11] 38 follow-up duration, 5, 7, 8, 38 population studied, 5,8,10 age distribution 9,11 and exclusion criteria. 7, [9] [10] [11] This high variability in identifying new cases of COPD among different studies may be associated with the fact that the samples of some of the studies did not include subjects who reported asthma, 9,11 as well as differences in follow-up periods, which ranged from 7 to 25 years.
One of the limitations of the present study is the rate of losses from the follow-up, which exceeded 20%. However, a European multicenter longitudinal study over a similar follow-up period reported a participation rate of 63.3%. 11 In addition, the group formed by the cases of loss from the follow-up and refusal to participate had the same clinical and pulmonary function characteristics as shown by the participants in the follow-up phase of the PLATINO study. Another limitation is the fact that there was only one re-evaluation after a period of nine years, which does not allow the incidence rates to be expressed as numbers of cases/ year, although the perceptual value could be presented and used in comparisons with other studies.
CONCLUSION
We conclude that the rate of diagnosing new cases of COPD in the city of São Paulo at the end of a nine-year follow-up period was similar to the percentages found in European, Asian and North American countries, with a range from 1.4% to 4.0%, depending on the spirometric criterion used for diagnosing the disease, with concordance levels of 35-60%. Therefore, researchers should concentrate their efforts on determining which spirometric criterion is the most accurate one for diagnosing COPD, so that epidemiological studies can better report the impact of this disease and the real responses of subjects to the treatment prescribed.
